|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro显示文摘 | GARRETT I R CHEN D GUTIERREZ G | 2003 | J Clin Invest2003，111，11： | 1 |
| 2 | Components and systems for long- wavelength monomode fibre transmission 显示文摘 | Garrett I Todd C | 1982 | J Opt Quan Electron1982，14，2： | 1 |
| 3 | Statins and bone formation 显示文摘 | GARRETT I R GUTIERREZ G MUNDY G R | 2001 | Curr Pharm Des2001，7，8： | 1 |
| 4 | To what extent did stock index fu- tures contribute to the october 1987 stock mar- ket crash? 显示文摘 | ANTONIOU A GARRETT I | 1993 | The Economic Joum~1993，103，421： | 1 |
| 5 | Stimulation of new bone formation by the proteasome inhibitor,bortezomib:implications for myeloma bone disease显示文摘 | OYAJOBI B O GARRETT I R GUPTA A | 2007 | Brj Haematol2007，139，3： | 1 |
| 6 | Review of an internal charging code, nu- mit显示文摘 | Jun I Garrett H B Kim W | 2008 | IEEE Transactions on Plasma Science2008，36，5： | 1 |
| 7 | Revenue management: research o- verview and prospects 显示文摘 | Jeffrey I M Garrett J V R | 1999 | Transportation Science1999，33，2： | 1 |
| 8 | Targeting the PI3K-AKTmTOR pathway:progress,pitfalls,and promises显示文摘 | Yap T A Garrett M D Walton M I | 2008 | Curr Opin Pharmacol2008，8，4： | 1 |
| 9 | Targeting the PI3K–AKT–mTOR pathway: progress, pitfalls, and promises显示文摘 | Timothy A Yap Michelle D Garrett Mike I Walton Florence Raynaud Johann S de Bono Paul Workman | 2008 | Current Opinion in Pharmacology2008，，4： | 1 |
| 10 | Targeting the PI3K-AKT- roTOR pathway : progress, pitfalls, and promises 显示文摘 | Yap T A Garrett M D Walton M I | 2008 | Current opinion in pharmacology2008，2，4： | 1 |
| 11 | Review of an internal charging code, NUMIT显示文摘 | JUN I GARRETT H B KIM W | 2008 | IEEE Transactions on Plasma Science2008，36，5： | 1 |
| 12 | Testing the importance of p27 degradation by the SCFskp2 pathway in murinemodels of lung and colon cancer 显示文摘 | Timmerbeul I Garrett - Engele CM Kossatz U | 2006 | Proc Natl Acad Sci USA2006，103，14： | 1 |
| 13 | Selective Inhibitors of the Osteoblast Proteasome Stimulate Bone Formation in Vivo and in Vitro显示文摘 | Garrett I R Chen D Gutierrez G | 2003 | J Clin Invest2003，111，： | 1 |
| 14 | Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs显示文摘 | Garrett J E Capuano I V Hammerland L G | 1995 | J Biol Chem1995，270，12： | 1 |
| 15 | A comparative study of the in- testinal micrabiota of healthy horses and those suffering from e- quine grass sickness显示文摘 | Garrett L A Brovoa R Poxton I R | 2002 | Veterinary Microbiology2002，，87： | 1 |
| 16 | Stimulation of New Bone Formation by the Proteasome Inhibitor, Bortezomib :Implications for Myeloma Bone Disease显示文摘 | Oyajobi B O Garrett I R Gupta A | 2007 | Br J Haematol2007，139，： | 1 |
| 17 | The Tragedy of the Commons 显示文摘 | I Garrett Hardin | 1968 | Science1968，，162： | 1 |
| 18 | The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation,causes loss of Cyclin D1,and activates the mitogen-activated protein kinase pathway显示文摘 | Whittaker S R Walton M I Garrett M D | 2004 | Cancer Res2004，64，1： | 1 |
| 19 | Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro显示文摘 | Garrett I R Chen D Gutierrez G | 2003 | J ClinInvest2003，111，11： | 1 |
| 20 | Stimulation of new bone formation by the proteasome inhibitor, bortezomib: implications for myeloma bone disease显示文摘 | Oyajobi B O Garrett I R Gupta A | 2007 | Br J Haematol2007，139，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员